General Hospital Psychiatry
Volume 27, Issue 4 , Pages 298-300 , July 2005

Treatment of psychomotor agitation and self-injurious behavior with estrogen and progesterone in a patient with Sanfilippo syndrome

Received 8 November 2004 ,Accepted 17 February 2005.

References 

  1. King BH, DeAntonio C, McCracken JT, Forness SR, Ackerland V. Psychiatric consultation in severe and profound mental retardation. Am J Psychiatry. 1994;151:1802–1808
  2. Madrid AL, State MW, King BH. Pharmacologic management of psychiatric and behavioral symptoms in mental retardation. Child Adolesc Psychiatr Clin N Am 2000;9:225–43, x–xi.
  3. Ryan JM. Pharmacologic approach to aggression in neuropsychiatric disorders. Semin Clin Neuropsychiatry. 2000;5:238–249
  4. Taylor DV, Rush D, Hetrick WP, Sandman CA. Self-injurious behavior within the menstrual cycle of women with mental retardation. Am J Ment Retard. 1993;97:659–664
  5. Quint EH, Elkins TE, Sorg CA, Kope S. The treatment of cyclical behavioral changes in women with mental disabilities. J Pediatr Adolesc Gynecol. 1999;12:139–142
  6. Carr EG, Smith CE, Giacin TA, Whelan BM, Pancari J. Menstrual discomfort as a biological setting event for severe problem behavior: assessment and intervention. Am J Ment Retard. 2003;108:117–133
  7. Keefe DL. Sex hormones and neural mechanisms. Arch Sex Behav. 2002;31:401–403
  8. Yogalingam G, Hopwood JJ. Molecular genetics of mucopolysaccharidosis type IIIA and IIIB: diagnostic, clinical, and biological implications. Hum Mutat. 2001;18:264–281
  9. Barone R, Nigro F, Triulzi F, et al. Clinical and neuroradiological follow-up in mucopolysaccharidosis type III (Sanfilippo syndrome). Neuropediatrics. 1999;30:270–274
  10. Bax MC, Colville GA. Behaviour in mucopolysaccharide disorders. Arch Dis Child. 1995;73:77–81
  11. Hier DB, Ahluwalie S, Melyn M, Hoganson GE. Estrogens control aggressive behavior in some patients with Sanfilippo syndrome. Neurol Res. 1999;21:611–612
  12. Petitti DB. Clinical practice. Combination estrogen–progestin oral contraceptives. N Engl J Med. 2003;349:1443–1450
  13. Rudick CN, Woolley CS. Estrogen regulates functional inhibition of hippocampal CA1 pyramidal cells in the adult female rat. J Neurosci. 2001;21:6532–6543
  14. McEwen B. Estrogen actions throughout the brain. Recent Prog Horm Res. 2002;57:357–384
  15. Kelly MJ, Qiu J, Ronnekleiv OK. Estrogen modulation of G-protein-coupled receptor activation of potassium channels in the central nervous system. Ann N Y Acad Sci. 2003;1007:6–16
  16. Kulkarni J, de Castella A, Smith D, et al. A clinical trial of the effects of estrogen in acutely psychotic women. Schizophr Res. 1996;20:247–252
  17. Kuppers E, Ivanova T, Karolczak M, Beyer C. Estrogen: a multifunctional messenger to nigrostriatal dopaminergic neurons. J Neurocytol. 2000;29:375–385
  18. Rettenbacher MA, Mechtcheriakov S, Bergant A, Brugger A, Fleischhacker WW. Improvement of psychosis during treatment with estrogen and progesterone in a patient with hypoestrogenemia. J Clin Psychiatry. 2004;65:275–277
  19. Kyomen HH, Nobel KW, Wei JY. The use of estrogen to decrease aggressive physical behavior in elderly men with dementia. J Am Geriatr Soc. 1991;39:1110–1112
  20. Kyomen HH, Satlin A, Hennen J, Wei JY. Estrogen therapy and aggressive behavior in elderly patients with moderate-to-severe dementia: results from a short-term, randomized, double-blind trial. Am J Geriatr Psychiatry. 1999;7:339–348
  21. Shelton PS, Brooks VG. Estrogen for dementia-related aggression in elderly men. Ann Pharmacother. 1999;33:808–812
  22. Arafat ES, Hargrove JT, Maxson WS, et al. Sedative and hypnotic effects of oral administration of micronized progesterone may be mediated through its metabolites. Am J Obstet Gynecol. 1988;159:1203–1209
  23. Bitran D, Hilvers RJ, Kellogg CK. Anxiolytic effects of 3 alpha-hydroxy-5 alpha[beta]-pregnan-20-one: endogenous metabolites of progesterone that are active at the GABAA receptor. Brain Res. 1991;561:157–161
  24. Soderpalm AH, Lindsey S, Purdy RH, Hauger R, Wit de H. Administration of progesterone produces mild sedative-like effects in men and women. Psychoneuroendocrinology. 2004;29:339–354
  25. Stell BM, Brickley SG, Tang CY, Farrant M, Mody I. Neuroactive steroids reduce neuronal excitability by selectively enhancing tonic inhibition mediated by delta subunit-containing GABAA receptors. Proc Natl Acad Sci U S A. 2003;100:14439–14444
  26. Smith MJ, Keel JC, Greenberg BD, et al. Menstrual cycle effects on cortical excitability. Neurology. 1999;53:2069–2072
  27. Smith SS, Gong QH, Hsu FC, et al. GABA(A) receptor alpha4 subunit suppression prevents withdrawal properties of an endogenous steroid. Nature. 1998;392:926–930

PII: S0163-8343(05)00035-6

doi: 10.1016/j.genhosppsych.2005.02.005

General Hospital Psychiatry
Volume 27, Issue 4 , Pages 298-300 , July 2005

Article Tools